Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion - PubMed (original) (raw)

Meta-Analysis

Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion

Jeffrey L Carson et al. Cochrane Database Syst Rev. 2012.

Update in

Abstract

Background: Most clinical practice guidelines recommend restrictive red cell transfusion practices, with the goal of minimising exposure to allogeneic blood. The purpose of this review is to compare clinical outcomes in patients randomised to restrictive versus liberal transfusion thresholds (triggers).

Objectives: To examine the evidence for the effect of transfusion thresholds on the use of allogeneic and/or autologous red cell transfusion, and the evidence for any effect on clinical outcomes.

Search methods: We identified trials by searching; The Cochrane Injuries Group Specialised Register (searched 01 Feb 2011), Cochrane Central Register of Controlled Trials 2011, issue 1 (The Cochrane Library), MEDLINE (Ovid) 1948 to January Week 3 2011, EMBASE (Ovid) 1980 to 2011 (Week 04), ISI Web of Science: Science Citation Index Expanded (1970 to Feb 2011), ISI Web of Science: Conference Proceedings Citation Index- Science (1990 to Feb 2011). We checked reference lists of other published reviews and relevant papers to identify any additional trials.

Selection criteria: Controlled trials in which patients were randomised to an intervention group or to a control group. Trials were included where intervention groups were assigned on the basis of a clear transfusion 'trigger', described as a haemoglobin (Hb) or haematocrit (Hct) level below which a red blood cell (RBC) transfusion was to be administered.

Data collection and analysis: Risk ratios of requiring allogeneic blood transfusion, transfused blood volumes and other clinical outcomes were pooled across trials, using a random effects model. Data extraction and assessment of the risk of bias was performed by two people.

Main results: Nineteen trials involving a total of 6264 patients were identified, and were similar enough that the results could be combined. Restrictive transfusion strategies reduced the risk of receiving a RBC transfusion by 39% (RR 0.61, 95% CI 0.52 to 0.72). This equates to an average absolute risk reduction (ARR) of 34% (95% CI 24% to 45%). The volume of RBCs transfused was reduced on average by 1.19 units (95% CI 0.53 to 1.85 units). However, heterogeneity between trials was statistically significant (P<0.00001; I(2)≥93%) for these outcomes. Restrictive transfusion strategies did not appear to impact the rate of adverse events compared to liberal transfusion strategies (i.e. mortality, cardiac events, myocardial infarction, stroke, pneumonia and thromboembolism). Restrictive transfusion strategies were associated with a statistically significant reduction in hospital mortality (RR 0.77, 95% CI 0.62-0.95) but not 30 day mortality (RR 0.85, 95% CI 0.70 to 1.03). The use of restrictive transfusion strategies did not reduce functional recovery, hospital or intensive care length of stay. The majority of patients randomised were included in good quality trials, but some items of methodological quality were unclear. There are no trials in patients with acute coronary syndrome.

Authors' conclusions: The existing evidence supports the use of restrictive transfusion triggers in most patients including those with pre-existing cardiovascular disease. As there are no trials, the effects of restrictive transfusion triggers in high risk groups such as acute coronary syndrome need to be tested in further large clinical trials. In countries with inadequate screening of donor blood, the data may constitute a stronger basis for avoiding transfusion with allogeneic red cells.

PubMed Disclaimer

Figures

Update of

Comment in

Similar articles

Cited by

References

References to studies included in this review

    1. Blair SD, Janvrin SB, McCollum CN, Greenhalgh RM. Effect of early blood transfusion on gastrointestinal haemorrhage. British Journal of Surgery. 1986;73(10):783–5. - PubMed
    1. Bracey AW, Radovancevic R, Riggs SA, Houston S, Cozart H, Vaughn WK, et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion. 1999;39(10):1070–7. - PubMed
    1. Bush RL, Pevec WC, Holcroft JW. A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients. American Journal of Surgery. 1997;174(2):143–8. - PubMed
    1. Carson JL, Terrin ML, Barton FB, Aaron R, Greenburg AG, Heck DA, et al. A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture. Transfusion. 1998;38(6):522–9. - PubMed
    1. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GR, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. New England Journal of Medicine. 2011;365(26):2453–62. - PMC - PubMed

References to studies excluded from this review

    1. Vichinsky EP, Haberkern CM, Neumayr L, Earles AN, Black D, Koshy M, et al. The Preoperative Transfusion in Sickle Cell Disease Study Group A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. New England Journal of Medicine. 1995;333(4):206–13. - PubMed

References to studies awaiting assessment

    1. Cooper HA, Rao SV, Greenberg MD, Rumsey MP, Mckenzie M, Alcorn KW, et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT randomized pilot study) American Journal of Cardiology. 2011;108:1108–11. - PubMed

References to ongoing studies

    1. Carson JL, Noveck H. Myocardial Ischemia and Transfusion (MINT) http://www.ClinicalTrials.gov. [: NCT01167582]
    1. Reeves B. A multi-centre randomised controlled trial of the effects of a reduction in the threshold for blood transfusion following heart surgery. http://www.controlled-trials.com. [: ISRCTN70923932]

Additional references

    1. Association of Anaesthetists of Great Britain and Ireland Blood transfusion and the anaesthetist - red cell transfusion. 2008 Jun 1-20; http://www.aagbi.org/publications/guidelines/docs/redcell08.pdf
    1. Amin M, Fergusson D, Wilson K, Tinmouth A, Aziz A, Coyle D, et al. The societal unit cost of allogenic red blood cells and red blood cell transfusion in Canada. Transfusion. 2004;44(10):1479–86. - PubMed
    1. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies Practice guidelines for perioperative blood transfusion and adjuvant therapies. Anesthesiology. 2006;105(1):198–208. - PubMed
    1. National Health and Medical Research Council (NHMRC) Australasian Society of Blood Transfusion (ASBT) Clinical Practice Guidelines: Appropriate Use of Red Blood Cells. 2001
    1. Guidelines for Red Blood Cell Transfusion. British Columbia Transfusion Medicine Advisory Group; Nov 1-3, 2003.

Publication types

MeSH terms

Substances

LinkOut - more resources